 |
The MIND program, directed by Dr. Staci Gruber, is designed to examine the unique and synergistic effects of cannabis and its constituents to determine the efficacy of cannabinoids for specific conditions and diseases and to clarify the overall impact of cannabinoid treatment on physical and mental health. Despite these rapid changes in the law, many policy makers, consumers, physicians, and the general public remain misinformed about cannabis. The MIND program aims to close the gap between policy and science by utilizing cognitive and clinical assessments, as well as multimodal neuroimaging techniques. The MIND�s mission is to harness the therapeutic potential while minimizing harms of cannabinoid-based treatment in order to improve patients� overall wellbeing. The MIND program supports a number of projects which evaluate commercially available and custom-formulated cannabinoid-based therapies for a range of conditions using longitudinal, observational, cross-sectional, survey, and clinical trial models For more information about the MIND program, please click here. | |
|
||
